Javadi Alireza
Chief Technical Officer
Javadi Alireza has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 29, 2026.
On the most recent filing, Javadi Alireza is listed as Chief Technical Officer at Rani Therapeutics Holdings, Inc. Inside the rolling window, Javadi Alireza reported no open-market purchases and 1 open-market sale totaling $301 in RANI.
Companies traded
Other insiders at RANI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$301
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Javadi Alireza made?
Javadi Alireza has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Javadi Alireza trade?
Javadi Alireza has filed SEC Form 4 disclosures for 1 company, including RANI.
When was Javadi Alireza's most recent SEC Form 4 filing?
Javadi Alireza's most recent SEC Form 4 filing on Tracefour is dated Sep 29, 2026.
What is Javadi Alireza's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Javadi Alireza is listed as Chief Technical Officer.
What is Javadi Alireza's total buy and sell value in the current window?
Inside the rolling retention window, Javadi Alireza bought $0 and sold $301 based on SEC Form 4 filings.
What was Javadi Alireza's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 386 RANI shares on 2026-03-27, worth $301, per SEC Form 4 filings.